InvestorsObserver
×
News Home

Do Traders Think Jaguar Health Inc (JAGX) Can Keep Climbing Wednesday?

Wednesday, June 02, 2021 11:13 AM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Jaguar Health Inc (JAGX) Can Keep Climbing Wednesday?

Jaguar Health Inc (JAGX) stock has risen 24.34% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bullish
Jaguar Health Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on JAGX!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With JAGX Stock Today?

Jaguar Health Inc (JAGX) stock is trading at $1.89 as of 11:06 AM on Wednesday, Jun 2, a gain of $0.09, or 5% from the previous closing price of $1.80. The stock has traded between $1.72 and $1.92 so far today. Volume today is 10,180,913 compared to average volume of 12,272,111.

To screen for more stocks like Jaguar Health Inc click here.

More About Jaguar Health Inc

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.

Click Here to get the full Stock Score Report on Jaguar Health Inc (JAGX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App